Biovaxy has up listed twice so far First to the U.S. otc then to the Venture exchange
VANCOUVER, BC , May 19, 2021 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV), (FRA: 5LB), (OTCQB: BVAXF) ("BioVaxys"), the world leader in haptenized antigen vaccines for antiviral and cancer applications, is pleased to announce that it is has been uplisted from the OTC Pink Sheets to the OTCQB Venture Market in the United States . Effective today, BioVaxys shares trade on OTCQB under the symbol BVAXF and will continue to trade on the CSE as BIOV and Frankfurt